Charlie's Holdings, Inc. (CHUC) stock
CHUCOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
$0.11+0.01 (+13.30%)
Close on Oct 19, 2026Market cap $31.05MP/E –Yield –
Charlie's total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Charlie's's total debt was $1.09M at Jun 30, 2023. For fiscal 2022 it was $150.00K, up 0.0% from the year before. The highest annual figure on record is $7.81M in fiscal 2018.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $150.00K | 0.0% |
| FY2021 | Dec 31, 2021 | $150.00K | -85.2% |
| FY2020 | Dec 31, 2020 | $1.02M | – |
| FY2019 | Dec 31, 2019 | $0 | -100.0% |
| FY2018 | Dec 31, 2018 | $7.81M | +177.6% |
| FY2017 | Dec 31, 2017 | $2.81M | +2466.1% |
| FY2016 | Dec 31, 2016 | $109.68K | -91.8% |
| FY2015 | Dec 31, 2015 | $1.34M | -68.6% |
| FY2014 | Dec 31, 2014 | $4.26M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2023 | Jun 30, 2023 | $1.09M | +629.3% |
| Q1 FY2023 | Mar 31, 2023 | $1.12M | +643.3% |
| Q4 FY2022 | Dec 31, 2022 | $150.00K | 0.0% |
| Q3 FY2022 | Sep 30, 2022 | $150.00K | -55.1% |
| Q2 FY2022 | Jun 30, 2022 | $150.00K | -55.1% |
| Q1 FY2022 | Mar 31, 2022 | $150.00K | -84.8% |
| Q4 FY2021 | Dec 31, 2021 | $150.00K | -85.2% |
| Q3 FY2021 | Sep 30, 2021 | $334.00K | -67.1% |
| Q2 FY2021 | Jun 30, 2021 | $334.00K | – |
| Q1 FY2021 | Mar 31, 2021 | $985.00K | -71.0% |
| Q4 FY2020 | Dec 31, 2020 | $1.02M | -87.0% |
| Q3 FY2020 | Sep 30, 2020 | $1.02M | -50.9% |
| Q4 FY2019 | Dec 31, 2019 | $0 | -100.0% |
| Q1 FY2019 | Mar 31, 2019 | $3.39M | +53.2% |
| Q4 FY2018 | Dec 31, 2018 | $7.81M | +177.6% |
| Q3 FY2018 | Sep 30, 2018 | $2.07M | +302.6% |
| Q2 FY2018 | Jun 30, 2018 | $2.07M | +218.8% |
| Q1 FY2018 | Mar 31, 2018 | $2.22M | +1145.9% |
| Q4 FY2017 | Dec 31, 2017 | $2.81M | +2466.1% |
| Q3 FY2017 | Sep 30, 2017 | $514.35K | +125.6% |
| Q2 FY2017 | Jun 30, 2017 | $649.73K | – |
| Q1 FY2017 | Mar 31, 2017 | $177.80K | – |
| Q4 FY2016 | Dec 31, 2016 | $109.68K | – |
| Q3 FY2016 | Sep 30, 2016 | $228.04K | – |
See a number that looks wrong?